Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Labcorp Holdings ( (LH) ) has issued an announcement.
On October 8, 2025, Labcorp Holdings Inc. announced that its Board of Directors declared a cash dividend of $0.72 per share of common stock, payable on December 11, 2025, to stockholders of record as of November 26, 2025. This announcement reflects Labcorp’s commitment to returning value to its shareholders and may enhance its market positioning by attracting and retaining investors.
The most recent analyst rating on (LH) stock is a Hold with a $290.00 price target. To see the full list of analyst forecasts on Labcorp Holdings stock, see the LH Stock Forecast page.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
Labcorp Holdings demonstrates strong financial management and positive technical indicators, contributing to a favorable outlook. The company’s robust earnings call and strategic initiatives further enhance its position. However, high valuation metrics and potential regulatory risks temper the overall score.
To see Spark’s full report on LH stock, click here.
More about Labcorp Holdings
Labcorp Holdings Inc. is a global leader in innovative and comprehensive laboratory services, providing diagnostics and drug development capabilities to doctors, hospitals, pharmaceutical companies, researchers, and patients. The company supports 75% of new drugs and therapeutic products approved by the FDA and performs over 700 million tests annually across approximately 100 countries.
Average Trading Volume: 619,953
Technical Sentiment Signal: Buy
Current Market Cap: $22.86B
Find detailed analytics on LH stock on TipRanks’ Stock Analysis page.